Related Articles by Review for PMID: 33085416

Year	Number of Results
1996	1
1999	1
2002	1
2007	1
2013	1
2015	1
2022	1
2023	1
2024	4
2025	1

1

Grimes WR, Dunton CJ, Stratton M. Grimes WR, et al. 2024 Feb 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Feb 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 33085416 Free Books & Documents.

2

Trends and current aspects of reconstructive surgery for gynecological cancers.

Loverro M, Aloisi A, Tortorella L, Aletti GD, Kumar A. Loverro M, et al. Int J Gynecol Cancer. 2024 Mar 4;34(3):426-435. doi: 10.1136/ijgc-2023-004620. Int J Gynecol Cancer. 2024. PMID: 38438169 Review.

3

R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond.

Xu C, Garda AE, Kumar A. Xu C, et al. Curr Treat Options Oncol. 2023 Apr;24(4):262-273. doi: 10.1007/s11864-023-01055-6. Epub 2023 Feb 27. Curr Treat Options Oncol. 2023. PMID: 36847987 Review.

4

Current status of robot-assisted total pelvic exenteration focusing on the field of urology: a clinical practice review.

Kamei J, Fujimura T. Kamei J, et al. Transl Cancer Res. 2024 Jan 31;13(1):453-461. doi: 10.21037/tcr-23-1039. Epub 2024 Jan 9. Transl Cancer Res. 2024. PMID: 38410226 Free PMC article. Review.

5

Complications of radical cystectomy.

Buscarini M, Pasin E, Stein JP. Buscarini M, et al. Minerva Urol Nefrol. 2007 Mar;59(1):67-87. Minerva Urol Nefrol. 2007. PMID: 17431372 Review.

6

Recurrent vulvar cancer.

Salom EM, Penalver M. Salom EM, et al. Curr Treat Options Oncol. 2002 Apr;3(2):143-53. doi: 10.1007/s11864-002-0060-x. Curr Treat Options Oncol. 2002. PMID: 12057077 Review.

7

Pelvic exenteration for advanced pelvic malignancy.

Crowe PJ, Temple WJ, Lopez MJ, Ketcham AS. Crowe PJ, et al. Semin Surg Oncol. 1999 Oct-Nov;17(3):152-60. doi: 10.1002/(sici)1098-2388(199910/11)17:3<152::aid-ssu3>3.0.co;2-j. Semin Surg Oncol. 1999. PMID: 10504662 Review.

8

Minimally invasive pelvic exenteration for gynaecological malignancy: A single-centre case series and review of the literature.

Karkia R, Tailor A, Ellis P, Madhuri T, Scala A, Read J, Perry M, Patil K, Blackburn A, Butler-Manuel S, Chatterjee J. Karkia R, et al. Eur J Obstet Gynecol Reprod Biol. 2022 Jul;274:56-61. doi: 10.1016/j.ejogrb.2022.05.003. Epub 2022 May 11. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35584578 Review.

9

Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.

Jäger L, Nilsson PJ, Rådestad AF. Jäger L, et al. Int J Gynecol Cancer. 2013 May;23(4):755-62. doi: 10.1097/IGC.0b013e318287a874. Int J Gynecol Cancer. 2013. PMID: 23407096 Review.

10

Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.

Lakhman Y, Nougaret S, Miccò M, Scelzo C, Vargas HA, Sosa RE, Sutton EJ, Chi DS, Hricak H, Sala E. Lakhman Y, et al. Radiographics. 2015 Jul-Aug;35(4):1295-313. doi: 10.1148/rg.2015140313. Radiographics. 2015. PMID: 26172364 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 33085416

12 results

Results by year